Frits van Coevorden - Concepedia

Author

Frits van Coevorden

Also Known As

C Punt, Coevorden, F. van, F Van Coevorden, F van Coevorden, F. V. COEVORDEN, F. Van Coevorden, F. van Coevorden, F.v. Coevorden, Frits Coevorden, Frits Van Coevorden

207

Publications

15.2K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Leiden University Medical Center Fondazione IRCCS Istituto Nazionale dei Tumori Institut Gustave Roussy Erasmus MC Cancer Institute

About

Frits van Coevorden is an author at The Netherlands Cancer Institute specializing in medicine, surgical oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	59	6.4K
2	Health Sciences	13	13	1.3K
3	Engineering	4	4	219
4	Biomedical Engineering	2	2	76
5	Biostatistics	1	1	31

Frits van Coevorden

109

Publications

13.3K

Citations

H-Index

Page 1

	Year	Citations
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	1.6K
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	747
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial Theo J. M. Ruers, Frits van Coevorden, Cornelis J.A. Punt, JNCI Journal of the National Cancer Institute	2017	657
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, Stefan Bielack, N. Abecassis, Annals of Oncology	2018	618
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial Penella J. Woll, Peter Reichardt, Axel Le Cesne, The Lancet Oncology Surgical OncologySoft-tissue SarcomaMedicineEortc 62931Metronomic Therapy	2012	572
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken, The Lancet Oncology Surgical OncologyChemotherapy Versus ChemoradiotherapyGastrointestinal OncologyResectable Gastric CancerMedicine	2018	562
Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS) Alessandro Gronchi, Rosalba Miceli, Sylvie Bonvalot, Annals of Surgery	2016	529
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux, The Lancet Oncology Surgical OncologyPrimary Retroperitoneal SarcomaRadiation TherapyMedicineSurgery	2020	446
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004) Theo J. M. Ruers, Cornelis J.A. Punt, Frits van Coevorden, Annals of Oncology Surgical OncologyHepatologyRadiation TherapyRadiofrequency AblationMedicine	2012	434
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma E. Gortzak, Alberto Azzarelli, J. Buesa, European Journal of Cancer Surgical OncologyMalignant DiseaseMedicineMetronomic TherapyPathology	2001	376

Page 1